Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression
{ "Understanding Depression in Adolescents: Inflammation and Brain Chemistry", "This observational study is looking for 160 adolescents aged 14-21 who are experiencing depression. The goal is to understand why some adolescents don't respond to common antidepressant medications like fluoxetine or escitalopram. You would participate in a mild stress test called the Trier Social Stress Test (TSST), which helps researchers look at how stress affects inflammation (your body's response to injury or infection) and glutamate (a brain chemical) levels. Researchers will measure your depression symptoms at the beginning of the study and again after 12 weeks to see if these stress-related factors can predict how well you respond to treatment. To join, you must be post-pubertal and not taking certain medications that could interfere with the study. The study's status is currently unclear.", "design": "This is an observational study, meaning researchers will observe participants without assigning them to different treatment groups. It aims to enroll 160 participants.", "commitments": "You would undergo a modified Trier Social Stress Test (TSST). Your depression symptoms will be measured at the start of the study and again after 12 weeks.", "compensation": "Not stated in the trial record.", "follow_up": "Your depression symptoms will be followed for 12 weeks after the start of the study, and your clinical course will be followed for 18 months.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression
At a glance
Conditions
NCT05329441
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of California, Los Angeles
Los Angeles, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Tiffany Ho, Ph.D. · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Children's Depressing Rating Scale-Revisedbaseline and 12-week follow-up
Clinician-administered assessment of depression severity (dimensional) assessment of depression Clinician-administered assessment of depression severity (dimensional)
- Reynolds Adolescent Depression Scale-2 (RADS-2)baseline and 12-week follow-up
Self-report measure of depression severity (dimensional)
- Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-PL)baseline and 12-week follow-up
The K-SADS-PL is a semi-structured clinical interview designed to yield reliable and valid diagnoses of current and past history of Axis I disorders in children and adolescents. We will use the K-SADS-PL to determine whether a participant is currently depressed, in remission, experiencing relapse or a recurrent episode. From this interview, we will also obtain information such as age of depression onset, number of depressive episodes, medication and therapy usage and changes, etc